A CAMH study sheds light on the experiences of South Asians with schizophrenia in Canada.
A new CAMH study suggests that quitting cannabis substantially improved an important aspect of cognition in people with schizophrenia who were chronic cannabis users.
CAMH's Dr. Aristotle Voineskos, Slaight Family Centre for Youth in Transition Director, has just been named to the prestigious Top 40 Under 40 list of Canada’s top young movers and shakers. Dr. Voineskos is also Head of the Kimel Family Translational Imaging-Genetics Laboratory in CAMH's Campbell Institute.
Canada’s Lower-Risk Cannabis Use Guidelines, released today with the endorsement of key medical and public health organizations, provide 10 science-based recommendations to enable cannabis users to reduce their health risks.
A new CAMH brain imaging study shows for the first time that brain inflammation is significantly elevated in people with obsessive-compulsive disorder than in people without the condition. The study provides compelling evidence for a new potential direction for treating this anxiety disorder.